Form EFFECT Evoke Pharma Inc
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 18, 2025 |
| Accession Number: | 0001193125-25-322667 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Coforge delivers 49% YoY Growth, PAT increases 110% YoY
- Boston Medical Malpractice Attorney Dino M. Colucci Explains Legal Standards and Filing Deadlines for Malpractice Claims in Massachusetts
- NSJ Gold Corp. (NSJ) (9PZ) Announces Flow-Thru Financing for Exploration on Its Antimony 2.0 Property
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
